215 related articles for article (PubMed ID: 10554036)
1. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T
Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036
[TBL] [Abstract][Full Text] [Related]
2. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
[TBL] [Abstract][Full Text] [Related]
3. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
Aoki K; Yoshida T; Sugimura T; Terada M
Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
[TBL] [Abstract][Full Text] [Related]
4. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of molecular chaperone 78-kd glucose-regulated protein/immunoglobulin-binding protein expression involved in enhancement of human RS cell mutability.
Hirano J; Kita K; Sugaya S; Ichimura Y; Yamamori H; Nakajima N; Suzuki N
Pancreas; 2008 Jan; 36(1):e7-14. PubMed ID: 18192872
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
Hatanaka K; Suzuki K; Miura Y; Yoshida K; Ohnami S; Kitade Y; Yoshida T; Aoki K
J Gene Med; 2004 Oct; 6(10):1139-48. PubMed ID: 15452878
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.
Ozaki I; Mizuta T; Zhao G; Yotsumoto H; Hara T; Kajihara S; Hisatomi A; Sakai T; Yamamoto K
Cancer Res; 2000 Nov; 60(22):6519-25. PubMed ID: 11103822
[TBL] [Abstract][Full Text] [Related]
9. [The study of the effect of antisense oligonucleotide specific to K-ras point mutation on human pancreatic carcinoma cell PC-2].
Wang YX; Gao L; Ji ZZ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1387-90. PubMed ID: 16318775
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
Miura Y; Ohnami S; Yoshida K; Ohashi M; Nakano M; Ohnami S; Fukuhara M; Yanagi K; Matsushita A; Uchida E; Asaka M; Yoshida T; Aoki K
Cancer Lett; 2005 Jan; 218(1):53-62. PubMed ID: 15639340
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
12. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
13. An anti-K-ras ribozyme suppresses oncogene expression and cell growth of human pancreatic cancer.
Sakuma T; Kijima H; Nishi M; Abe Y; Yamazaki H; Mine T; Nakamura M; Ueyama Y
Tokai J Exp Clin Med; 2004 Jun; 29(2):35-42. PubMed ID: 15473338
[TBL] [Abstract][Full Text] [Related]
14. Differential display of expressed genes in pancreatic cancer cells.
Gardner-Thorpe J; Ito H; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2002 Apr; 293(1):391-5. PubMed ID: 12054612
[TBL] [Abstract][Full Text] [Related]
15. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model. Can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?
Morioka CY; Saito S; Machado MC; Ohzawa K; Kubrusly MS; Cunha JE; Watanabe A
In Vivo; 2004; 18(2):113-7. PubMed ID: 15113037
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
Ide Y; Miyoshi E; Nakagawa T; Gu J; Tanemura M; Nishida T; Ito T; Yamamoto H; Kozutsumi Y; Taniguchi N
Biochem Biophys Res Commun; 2006 Mar; 341(2):478-82. PubMed ID: 16434023
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a novel human pancreas-specific gene, pancpin, that is down-regulated in pancreatic cancer cells.
Ozaki K; Nagata M; Suzuki M; Fujiwara T; Miyoshi Y; Ishikawa O; Ohigashi H; Imaoka S; Takahashi E; Nakamura Y
Genes Chromosomes Cancer; 1998 Jul; 22(3):179-85. PubMed ID: 9624529
[TBL] [Abstract][Full Text] [Related]
18. Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide.
Cogoi S; Codognotto A; Rapozzi V; Meeuwenoord N; van der Marel G; Xodo LE
Biochemistry; 2005 Aug; 44(31):10510-9. PubMed ID: 16060660
[TBL] [Abstract][Full Text] [Related]
19. Identification and cloning of human G-protein gamma 7, down-regulated in pancreatic cancer.
Shibata K; Mori M; Tanaka S; Kitano S; Akiyoshi T
Biochem Biophys Res Commun; 1998 May; 246(1):205-9. PubMed ID: 9600093
[TBL] [Abstract][Full Text] [Related]
20. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
